Because even if you're not interested in drug-and-device-specific topics like the learned intermediary rule and the controversy over compulsory provision of experimental drugs to terminal patients, you may still benefit by learning about such wider topics as the difference between express and implied pre-emption, changes to Federal Rule of Evidence 502 and the attorney-client privilege, a conspectus of cases decided under the Class Action Fairness Act, and the identity of the go-to people for arranging defense-side amicus briefs.